GRI Bio, Inc.
GRI· Nasdaq
Released Mar 14, 2025, after the close
10-K filed Mar 14, 2025, 73 days after period end · 0001824293-25-000050
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$1.95M | -$2.00M | -$2.27M |
GRI Bio, Inc. · CIK 1824293 · Engraved from SEC EDGAR
| -$3.10M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.